CJ

Corinne Jenkins

#65 out of 1697 analysts
Goldman Sachs
Automatically Tracked
Tracking: 0 Updated: Jul 29 at 07:20 AM

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
133.88%
Gain +1.82%
Monthly
2.16%
Yearly
29.22%
Drawdown
25.79%
$253,396.4
Equity
Holdings
$0
Cash
$253,396.4
Investment
$0
$153,396.4
Profit +$4,538.17
Realized
$153,396.4
Unrealized
$0
Dividends
$0
$253,396.4
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
1.82%
Profit
$4,538.17
Win %
50%
This Week
Compared To Last Week
Gain
-1.23%
Profit
-$3,148.93
Win %
33%
This Month
Compared to last month
Gain
-5.92%
Profit
-$15,957.81
Win %
33%
This Year
Compared to last year
Gain
6.31%
Profit
$15,037.82
Win %
33%
Roivant Sciences Ltd logo
ROIV Roivant Sciences Ltd
+$80,314.83
Geron Corporation logo
GERN Geron Corporation
+$47,309.93
TG Therapeutics, Inc. logo
TGTX TG Therapeutics, Inc.
+$19,556.58
Altimmune, Inc. logo
ALT Altimmune, Inc.
+$16,006.77
Ideaya Biosciences Inc. logo
IDYA Ideaya Biosciences Inc.
+$13,174.5
Fulcrum Therapeutics Inc. logo
FULC Fulcrum Therapeutics Inc.
+$10,415.22
Rhythm Pharmaceuticals Inc. logo
RYTM Rhythm Pharmaceuticals Inc.
-$21,728.25
Harmony Biosciences Holdings, Inc. logo
HRMY Harmony Biosciences Holdings, Inc.
-$7,366.06
Aclaris Therapeutics, Inc. logo
ACRS Aclaris Therapeutics, Inc.
-$4,287.13
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
98
Longs Won
49/83 59%
Profit Factor
2.28
Profitability
Shorts Won
10/15 66%
Standard Deviation
$8,929.09
Average Win
$4,623.91
Best Trade
(Mar 25) $62,607.01
Sharpe Ratio
-42.83
Average Loss
-$3,061.9
Worst Trade
(Mar 15) -$25,439.16
Z-Score
-0.73 (53.66%)
Commissions
$0
Avg. Trade Length
1m 3w 3d
Expectancy
$1,565.27
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% <0.01% <0.01% 0.01% 0.11% 0.68% 3.06% 11.3% 35.71%
Consecutive Losing Trades 83 74 66 58 50 41 33 25 17 8
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
Symbol Quantity Cost Value Comm. Profit (&#36;) Gain (%) Change
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV